Suppr超能文献

鞘氨醇-1-磷酸(S1P)通过 S1P 受体 4 介导的 5-脂氧合酶活性抑制,在体外和体内产生强大的抗炎作用。

Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity.

机构信息

Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt/Main, Germany.

Department of Medicine 2, Hematology/Oncology, University Hospital, Goethe University, Frankfurt/Main, Germany.

出版信息

FASEB J. 2019 Feb;33(2):1711-1726. doi: 10.1096/fj.201800221R. Epub 2018 Sep 6.

Abstract

Sphingosine-1-phosphate (S1P) is involved in the regulation of important cellular processes, including immune-cell trafficking and proliferation. Altered S1P signaling is strongly associated with inflammation, cancer progression, and atherosclerosis; however, the mechanisms underlying its pathophysiologic effects are only partially understood. This study evaluated the effects of S1P in vitro and in vivo on the biosynthesis of leukotrienes (LTs), which form a class of lipid mediators involved in the pathogenesis of inflammatory diseases. Here, we report for the first time that S1P potently suppresses LT biosynthesis in Ca-ionophore-stimulated intact human neutrophils. S1P treatment resulted in intracellular Ca mobilization, perinuclear translocation, and finally irreversible suicide inactivation of the LT biosynthesis key enzyme 5-lipoxygenase (5-LO). Agonist studies and S1P receptor mRNA expression analysis provided evidence for a S1P receptor 4-mediated effect, which was confirmed by a functional knockout of S1P4 in HL60 cells. Systemic administration of S1P in wild-type mice decreased both macrophage and neutrophil migration in the lungs in response to LPS and significantly attenuated 5-LO product formation, whereas these effects were abrogated in 5-LO or S1P4 knockout mice. In summary, targeting the 5-LO pathway is an important mechanism to explain S1P-mediated pathophysiologic effects. Furthermore, agonism at S1P4 represents a novel effective strategy in pharmacotherapy of inflammation.-Fettel, J., Kühn, B., Guillen, N. A., Sürün, D., Peters, M., Bauer, R., Angioni, C., Geisslinger, G., Schnütgen, F., Meyer zu Heringdorf, D., Werz, O., Meybohm, P., Zacharowski, K., Steinhilber, D., Roos, J., Maier, T. J. Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity.

摘要

鞘氨醇-1-磷酸(S1P)参与调节包括免疫细胞迁移和增殖在内的重要细胞过程。改变 S1P 信号与炎症、癌症进展和动脉粥样硬化密切相关;然而,其病理生理效应的机制仅部分被理解。本研究评估了 S1P 在体外和体内对白细胞三烯(LTs)生物合成的影响,LTs 形成一类参与炎症性疾病发病机制的脂质介质。在这里,我们首次报道 S1P 强烈抑制钙离子载体刺激的完整人中性粒细胞中 LT 的生物合成。S1P 处理导致细胞内 Ca 动员、核周易位,最终不可逆地自杀失活 LT 生物合成关键酶 5-脂氧合酶(5-LO)。激动剂研究和 S1P 受体 mRNA 表达分析提供了 S1P 受体 4 介导作用的证据,HL60 细胞中 S1P4 的功能性敲除证实了这一点。野生型小鼠中 S1P 的系统给药降低了 LPS 刺激下肺部的巨噬细胞和中性粒细胞迁移,并显著减弱了 5-LO 产物的形成,而这些作用在 5-LO 或 S1P4 敲除小鼠中被消除。总之,靶向 5-LO 途径是解释 S1P 介导的病理生理效应的重要机制。此外,S1P4 的激动作用代表了炎症治疗中一种新的有效策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验